Question 1

What is Nektar Therapeutics's total costs & expenses?

Accepted Answer

Nektar Therapeutics (NKTR) reported total costs & expenses of $49.92M in Q1 2026.

Question 2

How has Nektar Therapeutics's total costs & expenses changed year-over-year?

Accepted Answer

Nektar Therapeutics's total costs & expenses decreased by 9.2% year-over-year, from $55M to $49.92M.

Question 3

What is the long-term trend for Nektar Therapeutics's total costs & expenses?

Accepted Answer

Over 4 years (2021 to 2025), Nektar Therapeutics's total costs & expenses has grown at a -22.7% compound annual growth rate (CAGR), from $548.01M to $195.33M.

Question 4

What does total costs & expenses mean?

Accepted Answer

This metric aggregates all operating costs, including research and development, selling, general, and administrative expenses, and other production-related outlays. It provides a comprehensive view of the total capital required to sustain the company's current business activities and pipeline development. Monitoring this figure helps assess the company's overall cost structure and operational efficiency relative to its revenue generation.

Line item	Three Months Ended March 31,	Three Months Ended March 31,
Research and development (including $1,708 and $208 for the three months ended March 31, 2026 and 2025, respectively, from a related party)	35,680	30,480
General and administrative	13,439	24,346
Restructuring and impairment	796	169
Total operating costs and expenses	49,915	54,995
Loss from operations	(39,054)	(44,535)
Non-operating income (expense):
Non-cash interest expense on liabilities related to the sales of future royalties	(7,942)	(4,974)
Interest income	4,242	2,874

Total costs & expenses at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Nektar Therapeutics's total costs & expenses.

Nektar Therapeutics NKTR Total costs & expenses